Question 1

What is congenital disorder of glycosylation type 1E?

Accepted Answer

Congenital disorder of glycosylation type 1E is a condition that affects the glycoprotein synthesis pathway and is part of the broader group of congenital disorders of glycosylation. It is caused by alterations in the DPM1 gene, which plays a critical role in glycoprotein production. The condition typically presents in early childhood with neurological challenges such as psychomotor delay and seizures. It is very rare, affecting fewer than 1 in a million individuals.

Question 2

What are the symptoms of congenital disorder of glycosylation type 1E?

Accepted Answer

Individuals with congenital disorder of glycosylation type 1E often exhibit early onset psychomotor delay, seizures, and hypotonia. Other common clinical features include distinctive facial dysmorphism, microcephaly, and ocular anomalies. A consistently observed laboratory finding in affected individuals is an elevated concentration of hepatic transaminases. Not all individuals experience every feature, and severity varies considerably.

Question 3

What causes congenital disorder of glycosylation type 1E?

Accepted Answer

Congenital disorder of glycosylation type 1E is caused by mutations in the DPM1 gene, which is essential for the proper synthesis and processing of glycoproteins. Disruption in the function of the DPM1 protein leads to abnormalities in glycosylation that affect multiple body systems. The condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the altered gene to be affected. This condition is more common when parents share a common ancestor because the likelihood of both being carriers is increased. Associated genes include DPM1.

Question 4

How is congenital disorder of glycosylation type 1E inherited?

Accepted Answer

congenital disorder of glycosylation type 1E follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is congenital disorder of glycosylation type 1E?

Accepted Answer

congenital disorder of glycosylation type 1E is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is congenital disorder of glycosylation type 1E diagnosed?

Accepted Answer

Diagnosis is confirmed through molecular genetic testing that identifies pathogenic variants in DPM1. A comprehensive clinical evaluation, which considers the characteristic findings such as psychomotor delay, seizures, and elevated hepatic transaminase levels, is also essential. While specific biochemical markers beyond the genetic test are limited, careful clinical assessment helps differentiate this condition from others with similar features. Because many of these features can be seen in other conditions, genetic testing is essential to confirm the diagnosis.

Question 7

Are there treatments for congenital disorder of glycosylation type 1E?

Accepted Answer

Currently, management focuses on supportive care and symptom relief. Treatment is tailored to the individual and typically involves a multidisciplinary team, including specialists such as neurologists and metabolic experts. There are no established foundational therapies or FDA-approved treatments specifically for congenital disorder of glycosylation type 1E. Patients should discuss treatment options with their healthcare team to determine the most appropriate supportive interventions, and genetic counseling is recommended for affected families.

Question 8

What complications can arise from congenital disorder of glycosylation type 1E?

Accepted Answer

Congenital disorder of glycosylation type 1E can lead to various complications, particularly related to neurological development. Individuals may experience ongoing psychomotor delays and seizures, which can affect their daily functioning. Additionally, some may have issues with muscle tone, leading to hypotonia, which can impact mobility and overall health.

Question 9

How does congenital disorder of glycosylation type 1E affect daily life?

Accepted Answer

Living with congenital disorder of glycosylation type 1E can present daily challenges due to symptoms like psychomotor delay and seizures. Families often need to provide extra support for learning and physical activities. Regular visits to specialists, such as neurologists and metabolic experts, are also important for managing the condition effectively.

Question 10

What is the prognosis for someone with congenital disorder of glycosylation type 1E?

Accepted Answer

The prognosis for congenital disorder of glycosylation type 1E varies widely among individuals. While some may face significant challenges early in life, many can continue into adulthood with appropriate care and support. Ongoing research and improved standards of care may lead to better outcomes over time.

Question 11

What specialists should be involved in the care of someone with congenital disorder of glycosylation type 1E?

Accepted Answer

Care for someone with congenital disorder of glycosylation type 1E typically involves a multidisciplinary team. Key specialists include neurologists, who can help manage neurological symptoms, and metabolic experts, who understand the underlying metabolic issues. Working with a team ensures that all aspects of the individual's health are addressed effectively.

Organ System	Phenotype Count	Example Features
Brain and nerves	7	Seizure, Ataxia, Lower limb hyperreflexia
Muscles	7	Low muscle tone (hypotonia), Generalized hypotonia, Progressive muscle deterioration (muscular dystrophy)
Eyes	6	Strabismus, Nystagmus, Damage to the optic nerve (optic atrophy)
Arms and legs	3	Upper limb undergrowth, Lower limb hyperreflexia, Small hand
Digestive system	3	Enlarged liver (hepatomegaly), Elevated circulating hepatic transaminase concentration, Enlarged spleen (splenomegaly)
Lab test results	2	Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Elevated circulating hepatic transaminase concentration
Skin	2	Telangiectasia, Nail dysplasia
Head and neck	2	High, narrow palate, Secondary microcephaly
Growth and development	1	Failure to thrive
Blood and immune system	1	Enlarged spleen (splenomegaly)
Lungs and breathing	1	Respiratory distress

Kisho

congenital disorder of glycosylation type 1E

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

congenital disorder of glycosylation type 1E

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is congenital disorder of glycosylation type 1E?

What are the symptoms of congenital disorder of glycosylation type 1E?

What causes congenital disorder of glycosylation type 1E?

How is congenital disorder of glycosylation type 1E inherited?

How rare is congenital disorder of glycosylation type 1E?

How is congenital disorder of glycosylation type 1E diagnosed?

Are there treatments for congenital disorder of glycosylation type 1E?

What complications can arise from congenital disorder of glycosylation type 1E?

How does congenital disorder of glycosylation type 1E affect daily life?

What is the prognosis for someone with congenital disorder of glycosylation type 1E?

What specialists should be involved in the care of someone with congenital disorder of glycosylation type 1E?